Endoluxe, Mayo Clinic use edge computing, AI, ML to fight bladder cancer
Endoluxe has announced a partnership with Mayo Clinic as they come together to use artificial intelligence and machine learning to battle bladder cancer.
Mayo Clinic is harnessing the power of the Endoluxe Visualization System, a wireless endoscopic “smart” camera platform with edge computing capabilities. This technology provides AI-generated clinical insights to clinicians that can ultimately result in better patient outcomes.
Dr. Phil Zhao, Chief Medical Officer at Endoluxe, expressed enthusiasm for the partnership: “Working with Mayo Clinic clinicians will further advance Endoluxe’s surgical insights capabilities. We are excited to accelerate our cutting-edge technology platform for the benefit of patients”.
This system from Endoluxe provides an array of real-time data and clinical insights to clinicians during a surgical procedure. Endoluxe says this technology is currently unavailable on any other endoscopic platform.
Endoluxe was founded in the United States with a worldwide distribution of its award-winning Endoluxe Orb medical industry design. The company’s primary mission is to reduce costs related to legacy video platforms, improve patient outcomes through better therapy applications and enhance the adoption of procedures through its platform.
The company says its modern technology is more cost-effective than legacy products, as it costs one-fourth of the price.
This news follows other announcements from Endoluxe, such as their strategic partnership with Synopic to enter a development agreement to realize the technological synergies of both organizations.
StackPath, Edgevana offer Web 3 services for Solana participants
Article Topics
AI/ML | edge AI | Endoluxe | healthcare | Mayo Clinic
Comments